Introduction The Interstitial Lung Diseases (ILD) are a heterogeneous group of inflammatory and fibrotic diseases of the interstitium, with worst cases resulting in pulmonary fibrosis (PF). Increased neutrophils are found within the lung or bronchoalveolar lavage (BAL) in ILD and predict a poor prognosis. Neutrophil adhesion molecules, e.g., CD18/b2 integrins (LFA-1; CD11a, Mac-1; CD11b and CR3; CD11c) and L-Selectin (CD62L) regulate cellular recruitment and fibrosis in animal models of bleomycin-induced PF. Expression of the Fc receptor (CD16) is upregulated during neutrophil activation, whilst ICAM-1 (CD54) is a marker for neutrophil reverse-transmigration back across the endothelium. Background Neutrophilic inflammation is common in various diseases and may contribute to the pathophysiology of interstitial lung disease (ILD), however the underlying mechanism are not fully understood. Localised tissue hypoxia is often accompanied with inflammation, which may alter cellular responses to drive immunopathology. Hypothesis We propose that hypoxia modulates neutrophil functions including integrin activation, neutrophil extravasation and neutrophil extracellular trap (NET) release that may contribute to pulmonary damage in ILD Methods Pulmonary hypoxia was assessed using both fluoromisonidazole (FMISO)-PET scanning of ILD patients and immunohistochemical HIF-1a staining in ILD and control lung sections. To examine the effects of hypoxia, isolated neutrophils were cultured under hypoxia (1% oxygen) or normoxia (21% oxygen) prior to experimentation. Neutrophil integrin expression was evaluated using flow cytometry. Neutrophil
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